HAVN.C

The segment includes an in-depth interview with HAVN Life CEO, Tim Moore, as well as clips from Chief Psychedelic Officer, Dr. Ivan Casselman, and Chief Research Officer, Alexzander Samuelsson, where they discuss the Company's end-to-end research, extraction, formulation, and delivery of naturally derived psilocybin, and some of the stra... Read More...

20/20 Global, Inc.Mycotopia Therapies plans to distribute HAVN’s line of natural OTC health products currently being registered with the Jamaican Ministry of HealthMIAMI, March 17, 2022 -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychede... Read More...